Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
ARCT on Nasdaq
Shares outstanding
28,412,394
Price per share
$7.57
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
23,575,560
Total reported value
$144,513,022
% of total 13F portfolios
0%
Share change
-2,280,159
Value change
-$42,534,233
Number of holders
114
Price from insider filings
$7.57
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 12% $20,250,983 3,303,640 Federated Hermes, Inc. 31 Dec 2025
ARK Investment Management LLC 9.2% +48% $16,006,037 +$5,492,842 2,611,099 +52% ARK Investment Management LLC 31 Dec 2025
BlackRock, Inc. 7.8% $27,169,573 2,104,537 BlackRock, Inc. 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc. 7.2% +1.4% $35,898,599 +$400,871 1,947,835 +1.1% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 7.2% +1.4% $35,898,599 +$400,871 1,947,835 +1.1% Amova Asset Management Americas, Inc. 30 Sep 2025
VANGUARD GROUP INC 6.7% $23,550,428 1,810,165 The Vanguard Group 30 Jun 2025
STATE STREET CORP 4.9% $17,120,700 1,326,158 STATE STREET CORPORATION 31 Dec 2024

As of 31 Dec 2025, 114 institutional investors reported holding 23,575,560 shares of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT). This represents 83% of the company’s total 28,412,394 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FEDERATED HERMES, INC. 12% 3,303,640 -30% 0.03% $20,251,313
BlackRock, Inc. 9.2% 2,619,684 +2.1% 0% $16,058,662
ARK Investment Management LLC 9.2% 2,611,099 +39% 0.11% $16,006,036
VANGUARD GROUP INC 7.4% 2,089,641 +11% 0% $12,809,499
Sumitomo Mitsui Trust Group, Inc. 7.1% 2,026,588 +4% 0.01% $12,422,984
Amova Asset Management Americas, Inc. 7.1% 2,026,588 +4% 0.14% $12,402,719
GEODE CAPITAL MANAGEMENT, LLC 2.2% 618,134 +1% 0% $3,789,944
STATE STREET CORP 2% 564,266 -46% 0% $3,458,951
TWO SIGMA INVESTMENTS, LP 1.9% 546,686 +513% 0% $3,351,185
TWO SIGMA ADVISERS, LP 1.8% 511,043 +1227% 0.01% $3,132,694
DIMENSIONAL FUND ADVISORS LP 1.7% 490,429 -12% 0% $3,006,448
ACADIAN ASSET MANAGEMENT LLC 1.5% 427,894 +81% 0% $2,620,000
JANE STREET GROUP, LLC 1.5% 422,419 +210% 0% $2,589,428
Empire Life Investments Inc. 1.5% 412,402 -1.2% 0.14% $2,528,024
GOLDMAN SACHS GROUP INC 1.4% 391,227 +170% 0% $2,398,222
MILLENNIUM MANAGEMENT LLC 1.1% 304,777 +666% 0% $1,868,283
JACOBS LEVY EQUITY MANAGEMENT, INC 1% 293,050 -4.1% 0.01% $1,796,396
Hennion & Walsh Asset Management, Inc. 0.85% 240,303 +207% 0.05% $1,473,057
UBS Group AG 0.8% 227,893 +42% 0% $1,396,984
Point72 Asset Management, L.P. 0.78% 222,163 0% $1,361,859
MORGAN STANLEY 0.75% 213,392 -70% 0% $1,308,093
JPMORGAN CHASE & CO 0.73% 206,169 +1.3% 0% $1,263,817
NORTHERN TRUST CORP 0.71% 200,781 -7.8% 0% $1,230,788
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.65% 183,855 -12% 0% $1,127,031
BNP PARIBAS FINANCIAL MARKETS 0.52% 146,767 0% 0% $899,682

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 23,575,560 $144,513,022 -$42,534,233 $6.13 114
2025 Q3 25,813,853 $475,545,761 +$6,867,024 $18.43 134
2025 Q2 25,723,468 $335,038,354 -$6,831,289 $13.01 140
2025 Q1 26,575,062 $281,454,102 -$6,198,440 $10.59 141
2024 Q4 26,610,345 $451,455,958 +$561,441 $16.97 144
2024 Q3 26,254,849 $609,261,942 -$9,219,231 $23.21 163
2024 Q2 26,274,363 $639,738,709 -$34,874,203 $24.35 169
2024 Q1 27,205,455 $918,443,053 +$63,004,519 $33.77 176
2023 Q4 25,425,877 $801,644,603 +$9,906,113 $31.53 165
2023 Q3 25,171,045 $643,113,548 +$38,194,974 $25.55 146
2023 Q2 23,633,969 $677,565,419 +$11,461,734 $28.68 143
2023 Q1 23,320,944 $557,885,187 +$17,248,370 $23.97 124
2022 Q4 22,638,074 $383,920,663 +$11,521,684 $16.96 111
2022 Q3 22,166,410 $328,065,176 -$1,828,982 $14.82 106
2022 Q2 20,644,930 $334,480,556 +$9,251,825 $15.74 116
2022 Q1 21,454,944 $578,272,039 +$36,976,142 $26.96 122
2021 Q4 19,955,158 $736,203,155 +$29,436,784 $37.01 133
2021 Q3 19,065,552 $909,015,330 -$50,289,411 $47.78 150
2021 Q2 20,506,601 $693,959,237 +$36,673,317 $33.84 133
2021 Q1 18,787,112 $775,920,001 -$48,861,238 $41.30 153
2020 Q4 19,874,000 $864,074,837 +$70,349,611 $43.38 131
2020 Q3 18,215,804 $783,103,294 +$221,938,988 $42.90 127
2020 Q2 12,949,979 $605,805,587 +$388,736,954 $46.74 112
2020 Q1 4,735,510 $65,692,000 +$2,316,123 $13.59 53
2019 Q4 4,554,811 $50,089,000 -$172,871 $10.87 49
2019 Q3 4,612,453 $47,342,000 +$27,908,866 $10.27 39
2019 Q2 1,877,652 $17,728,000 +$17,719,999 $9.44 20